Held on April 24 at the Nihonbashi Life Science Building 201 large conference room.
Asia Partnership Conference of Regenerative Medicine (APACRM) has been held since 2018 with the mission “To expedite the development and availability of superior therapeutic products, such as regenerative medicine products, to Asian patients.”
Participants were recruited online and locally at the 8th APACRM from company associations and regulatory agencies in approximately 12 countries.
Chinese, Korean, and Taiwanese industry organizations introduced the latest trends in regenerative medicine regulations and APAC Regulatory Roadmap whitepaper.
Comparative national and regional discussions were conducted on the topics of A-Gene QbD approaches in gene therapy manufacturing, nonclinical data packages required for developing AAV gene therapy, Product Lifecycle Roadmap of gene therapy, and post-marketing regulatory requirements for regenerative medicine prodects.
-
Opening remarks: Representative president Shitaka -
Tracing the Path of APACRM: Advisor Nomura, of International affairs commitee -
Presentation and disscussion by ARM
-
Presentation by WG1 and enthusiastically listening audience -
Presentation by WG3 -
Panel discussion by representatives from Asian countries
